

share
Mniopetal E CAS NO 158761-02-5
Unit Price:
CAS No.:158761-02-5
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Mniopetal E is a specialized chemical compound of significant interest in advanced organic synthesis and pharmaceutical research. Its unique structural features make it a valuable intermediate for developing novel active pharmaceutical ingredients (APIs) and fine chemicals. This product is essential for R&D laboratories and production facilities in the pharmaceutical, agrochemical, and specialty chemical industries seeking high-purity building blocks for complex molecule construction.
Application
- Pharmaceutical Intermediate: A key building block in the synthesis of complex drug candidates and novel therapeutic agents.
- Agrochemical Research: Used in the development of new active ingredients for crop protection products.
- Fine Chemical Synthesis: Serves as a precursor for creating specialty chemicals with specific functional properties.
- Academic & Industrial R&D: Employed in research laboratories for methodological studies and the exploration of new chemical reactions.
- Material Science: Potential applications in the development of advanced organic materials and functional polymers.
Basic Information
| Item | Details |
|---|---|
| Product Name | Mniopetal E |
| CAS No. | 158761-02-5 |
| Molecular Formula | Contact for details |
| Molecular Weight | Contact for details |
| Synonyms | Mniopetal E; 158761-02-5; (2R,3R,4S,5S,6R)-2-[(2S,3S,4S,5R)-3,4-Dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol (IUPAC); Mniopetal E compound; Mniopetal-E |
| EINECS | Contact for details |
Quality Control
Our Mniopetal E is produced under strict quality management systems to ensure batch-to-batch consistency and high purity. The product undergoes rigorous analytical testing, including chromatography and spectroscopic methods, to meet the stringent requirements of research and industrial applications. A Certificate of Analysis (COA) detailing purity, identity, and impurity profiles is provided with each shipment to guarantee compliance with your specifications.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed when not in use to protect from moisture and contamination.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white solid |
| Identification (IR) | Conforms to reference spectrum |
| Purity (HPLC) | ≥ 95.0% |
| Water Content (KF) | ≤ 2.0% |
| Residue on Ignition | ≤ 0.5% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Phytosphingosine CAS NO 554-62-1


Biliverdin CAS NO 114-25-0


Xanthopterin CAS NO 119-44-8


Chola-3,5-Dienic Acid Methyl Ester CAS NO 1172-10-7


Albonoursin CAS NO 1222-90-8


Bilifuscin CAS NO 1398-21-6


Helleborein) CAS NO 1399-70-8


Radicinin CAS NO 1402-20-6


Actinomycin E1 CAS NO 1402-41-1


Gitalin (Amorphous) CAS NO 1405-76-1


Estrone 3-Methyl Ether CAS NO 1624-62-0


Fonsecin Monomethyl Ether CAS NO 1856-95-7


Biliverdin Dimethyl Ester CAS NO 10035-62-8


Mitraphyllic Acid CAS NO 10126-00-8


[1R-(1Alpha,4Abeta,4Balpha,10Aalpha)]-1,2,3,4,4A,4B,5,6,10,10A-Decahydro-1,4A-Dimethyl-7-(Isopropyl)Phenanthrene-1-Carboxylic Acid, Copper Salt CAS NO 10248-55-2


2,4 Diacetyl Deuteroporphyrin Ix Dimethyl Ester CAS NO 10591-31-8


Aurovertin CAS NO 11002-90-7


Entandrophragmin CAS NO 11013-05-1


Senfolomycin A CAS NO 11017-36-0


Victorin CAS NO 11026-16-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.





